» Articles » PMID: 16133353

The Manipulation of Chromosomes by Mankind: the Uses of Microcell-mediated Chromosome Transfer

Overview
Journal Chromosoma
Specialty Molecular Biology
Date 2005 Sep 1
PMID 16133353
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Microcell-mediated chromosome transfer (MMCT) was a technique originally developed in the 1970s to transfer exogenous chromosome material into host cells. Although, the methodology has not changed considerably since this time it is being used to great success in progressing several different fields in modern day biology. MMCT is being employed by groups all over the world to hunt for tumour suppressor genes associated with specific cancers, DNA repair genes, senescence-inducing genes and telomerase suppression genes. Some of these genomic discoveries are being investigated as potential treatments for cancer. Other fields have taken advantage of MMCT, and these include assessing genomic stability, genomic imprinting, chromatin modification and structure and spatial genome organisation. MMCT has also been a very useful method in construction and manipulation of artificial chromosomes for potential gene therapies. Indeed, MMCT is used to transfer mainly fragmented mini-chromosome between cell types and into embryonic stem cells for the construction of transgenic animals. This review briefly discusses these various uses and some of the consequences and advancements made by different fields utilising MMCT technology.

Citing Articles

PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer.

Luan W, Cheng H, Xie H, Liu H, Wang Y, Wang S Int J Mol Sci. 2024; 25(9).

PMID: 38732044 PMC: 11084440. DOI: 10.3390/ijms25094825.


Modeling specific aneuploidies: from karyotype manipulations to biological insights.

Truong M, Cane-Gasull P, Lens S Chromosome Res. 2023; 31(3):25.

PMID: 37640903 PMC: 10462580. DOI: 10.1007/s10577-023-09735-7.


Targeting chromosome trisomy for chromosome editing.

Abe T, Suzuki Y, Ikeya T, Hirota K Sci Rep. 2021; 11(1):18054.

PMID: 34508128 PMC: 8433146. DOI: 10.1038/s41598-021-97580-1.


Somatic Sex: On the Origin of Neoplasms With Chromosome Counts in Uneven Ploidy Ranges.

Haas O Front Cell Dev Biol. 2021; 9:631946.

PMID: 34422788 PMC: 8373647. DOI: 10.3389/fcell.2021.631946.


Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.

Uno N, Abe S, Oshimura M, Kazuki Y J Hum Genet. 2017; 63(2):145-156.

PMID: 29180645 DOI: 10.1038/s10038-017-0378-7.


References
1.
Huertas D, Howe S, McGuigan A, Huxley C . Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells. Hum Mol Genet. 2000; 9(4):617-29. DOI: 10.1093/hmg/9.4.617. View

2.
Fournier R, Ruddle F . Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci U S A. 1977; 74(1):319-23. PMC: 393251. DOI: 10.1073/pnas.74.1.319. View

3.
Bridger J, Bickmore W . Putting the genome on the map. Trends Genet. 1998; 14(10):403-9. DOI: 10.1016/s0168-9525(98)01572-8. View

4.
Arima T, Drewell R, Oshimura M, Wake N, Surani M . A novel imprinted gene, HYMAI, is located within an imprinted domain on human chromosome 6 containing ZAC. Genomics. 2000; 67(3):248-55. DOI: 10.1006/geno.2000.6266. View

5.
Tanaka H, Horikawa I, Barrett J, Oshimura M . Evidence for inactivation of distinct telomerase repressor genes in different types of human cancers. Int J Cancer. 2005; 115(4):653-7. DOI: 10.1002/ijc.20879. View